SEC Form 4 · accession 0001127602-17-014850
Bioverativ Inc. · BIVV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander J Denner
Director
Period of report
Apr 17, 2017
Accepted (ET)
Apr 17, 2017 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 17, 2017 | A | 1,056 | $56.83 | A | 5,001 | D | |
| Common StockF3,F4,F5,F6 | holding | — | — | — | 155,000 | I | See footnotes |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The common stock was issued to the reporting person pursuant to the 2017 Non-Employee Directors Plan in lieu of an annual retainer fee of $60,000.
- F2Includes 3,945 shares of common stock acquired in a pro rata distribution by Biogen in connection with the spin off of Bioverativ by Biogen on February 1, 2017.
- F3Represents shares of common stock acquired in a pro rata distribution by Biogen in connection with the spin off of Bioverativ by Biogen on February 1, 2017.
- F4Sarissa Capital Domestic Fund LP, a Delaware limited partnership ("Sarissa Domestic") and Sarissa Capital Offshore Master Fund, LP, a Cayman Islands exempted limited partnership ("Sarissa Offshore" and together with Sarissa Domestic, the "Sarissa Funds"), beneficially own an aggregate of 95,071 and 59,929 shares, respectively, of common stock of Bioverativ Inc.
- F5Alexander Denner, Ph.D. is the Chief Investment Officer of Sarissa Capital Management LP, a Delaware limited partnership ("Sarissa Capital"), the investment advisor to the Sarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended) the shares that the Sarissa Funds directly beneficially own.
- F6Dr. Denner disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.